1 |
Li W, You L, Cooper J et al (2010) Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell 140, 477-490
DOI
|
2 |
Li W, Cooper J, Zhou L et al (2014) Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus. Cancer Cell 26, 48-60
DOI
|
3 |
Deng J, Lei W, Xiang X et al (2016) Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway. Oncotarget 7, 10037-10050
|
4 |
Sang Y, Yan F and Ren X (2015) The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications. Oncotarget 6, 42590-42602
|
5 |
Ma B, Chen Y, Chen L et al (2015) Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol 17, 95-103
|
6 |
Kim M, Kim M, Park SJ, Lee C and Lim DS (2016) Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition. EMBO Rep 17, 64-78
DOI
|
7 |
Kim Y, Kim W, Song Y et al (2017) Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability. Proc Natl Acad Sci U S A 114, 4691-4696
DOI
|
8 |
Wei X, Shimizu T and Lai ZC (2007) Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J 26, 1772-1781
DOI
|
9 |
Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA and Sillje HH (2005) The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076-2086
DOI
|
10 |
Lignitto L, Arcella A, Sepe M et al (2013) Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth. Nat Commun 4, 1822
DOI
|
11 |
Tapon N, Harvey KF, Bell DW et al (2002) salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478
DOI
|
12 |
Callus BA, Verhagen AM and Vaux DL (2006) Vaux, Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J 273, 4264-4276
DOI
|
13 |
Praskova M, Xia F and Avruch J (2008) MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol 18, 311-321
DOI
|
14 |
Lee JH, Kim TS, Yang TH et al (2008) A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J 27, 1231-1242
DOI
|
15 |
Lu L, Li Y, Kim SM et al (2010) Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 107, 1437-1442
DOI
|
16 |
Aerne BL, Gailite I, Sims D and Tapon N (2015) Hippo Stabilises Its Adaptor Salvador by Antagonising the HECT Ubiquitin Ligase Herc4. PLoS One 10, e0131113
DOI
|
17 |
Poon CL, Lin JI, Zhang X and Harvey KF (2011) The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway. Dev Cell 21, 896-906
DOI
|
18 |
Boggiano JC, Vanderzalm PJ and Fehon RG (2011) Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway. Dev Cell 21, 888-895
DOI
|
19 |
Praskova M, Khoklatchev A, Ortiz-Vega S and Avruch J (2004) Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem J 381(Pt 2), 453-462
DOI
|
20 |
Yuan Z, Kim D, Shu S et al (2010) Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. J Biol Chem 285, 3815-3824
DOI
|
21 |
Collak FK, Yagiz K, Luthringer DJ, Erkaya B and Cinar B (2012) Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1. J Biol Chem 287, 23698-23709
DOI
|
22 |
Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84, 345-357
DOI
|
23 |
Xiao L, Chen D, Hu P et al (2011) The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death. J Neurosci 31, 9611-9619
DOI
|
24 |
Chen Y, Wang Z, Wang P, Li D, Zhou J and Wu S (2014) CYLD negatively regulates Hippo signaling by limiting Hpo phosphorylation in Drosophila. Biochem Biophys Res Commun 452, 808-812
DOI
|
25 |
Rodriguez-Boulan E and Nelson WJ (1989) Morphogenesis of the polarized epithelial cell phenotype. Science 245, 718-725
DOI
|
26 |
Chen CL, Gajewski KM, Hamaratoglu F et al (2010) The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc Natl Acad Sci U S A 107, 15810-15815
DOI
|
27 |
Varelas X, Samavarchi-Tehrani P, Narimatsu M et al (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 19, 831-844
DOI
|
28 |
Robinson BS, Huang J, Hong Y and Moberg KH (2010) Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol 20, 582-590
DOI
|
29 |
Ribeiro P, Holder M, Frith D, Snijders AP and Tapon N (2014) Crumbs promotes expanded recognition and degradation by the SCF(Slimb/beta-TrCP) ubiquitin ligase. Proc Natl Acad Sci U S A 111, E1980- E19809
DOI
|
30 |
Ling C, Zheng Y, Yin F et al (2010) The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc Natl Acad Sci U S A 107, 10532-10537
DOI
|
31 |
Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU and Jentsch S (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635-644
DOI
|
32 |
Meng Z, Moroishi T and Guan KL (2016) Mechanisms of Hippo pathway regulation. Genes Dev 30, 1-17
DOI
|
33 |
Zanconato F, Cordenonsi M and Piccolo S (2016) YAP/TAZ at the Roots of Cancer. Cancer Cell 29, 783-803
DOI
|
34 |
Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67, 425-479
DOI
|
35 |
Ikeda F and Dikic I (2008) Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep 9, 536-542
DOI
|
36 |
Kirisako T, Kamei K, Murata S et al (2006) A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J 25, 4877-4887
DOI
|
37 |
Li W, Bengtson MH, Ulbrich A et al (2008) Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signaling. PLoS One 3, e1487
DOI
|
38 |
Nijman SM, Luna-Vargas MP, Velds A et al (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786
DOI
|
39 |
Canning M, Boutell C, Parkinson J and Everett RD (2004) A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J Biol Chem 279, 38160-38168
DOI
|
40 |
Wu X, Yen L, Irwin L, Sweeney C and Carraway KL 3rd (2004) Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol Cell Biol 24, 7748-7757
DOI
|
41 |
Wertz IE, O'Rourke KM, Zhou H et al (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694-699
DOI
|
42 |
Hetfeld BK, Helfrich A, Kapelari B et al (2005) The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1. Curr Biol 15, 1217-1221
DOI
|
43 |
Brooks CL, Li M, Hu M, Shi Y and Gu W (2007) The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP. Oncogene 26, 7262-7266
DOI
|
44 |
Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A and Mosialos G (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424, 793-796
DOI
|
45 |
Liu CY, Zha ZY, Zhou X et al (2010) The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem 285, 37159-37169
DOI
|
46 |
Zhao B, Li L, Tumaneng K, Wang CY and Guan KL (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24, 72-85
DOI
|
47 |
Huang W, Lv X, Liu C et al (2012) The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem 287, 26245-26253
DOI
|
48 |
Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C and Hong W (2011) Hippo pathway-independent restriction of TAZ and YAP by angiomotin. J Biol Chem 286, 7018-7026
DOI
|
49 |
Tu K, Yang W, Li C et al (2014) Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Mol Cancer 13, 110
DOI
|
50 |
Wang W, Huang J, Wang X et al (2012) PTPN14 is required for the density-dependent control of YAP1. Genes Dev 26, 1959-1971
DOI
|
51 |
Wang W, Li N, Li X, Tran MK, Han X and Chen J (2015) Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins. Cell Rep 13, 524-532
DOI
|
52 |
Wang W, Huang J and Chen J (2011) Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 286, 4364-4370
DOI
|
53 |
Zhao B, Li L, Lu Q et al (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 25, 51-63
DOI
|
54 |
Wang C, An J, Zhang P et al (2015) The Nedd4-like ubiquitin E3 ligases target angiomotin/p130 to ubiquitindependent degradation. Biochem J 444, 279-289
|
55 |
Zhang Y, Liu S, Mickanin C et al (2011) RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol 13, 623-629
DOI
|
56 |
Thanh Nguyen H, Andrejeva D, Gupta R et al (2016) Deubiquitylating enzyme USP9x regulates hippo pathway activity by controlling angiomotin protein turnover. Cell Discov 2, 16001
|
57 |
Genevet A, Wehr MC, Brain R, Thompson BJ and Tapon N (2010) Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 18, 300-308
DOI
|
58 |
Huang J, Wu S, Barrera J, Matthews K and Pan D (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122, 421-434
DOI
|
59 |
Lei QY, Zhang H, Zhao B et al (2008) TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28, 2426-36
DOI
|
60 |
Hamaratoglu F, Willecke M, Kango-Singh M et al (2006) The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 8, 27-36
DOI
|
61 |
Yu FX, Zhao B, Panupinthu N et al (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791
DOI
|
62 |
Yu J, Zheng Y, Dong J, Klusza S, Deng WM and Pan D (2010) Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 18, 288-299
DOI
|
63 |
Visser-Grieve S, Zhou Z, She YM et al (2011) LATS1 tumor suppressor is a novel actin-binding protein and negative regulator of actin polymerization. Cell Res 21, 1513-1516
DOI
|
64 |
Mo JS, Yu FX, Gong R, Brown JH and Guan KL (2012) Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs). Genes Dev 26, 2138-2143
DOI
|
65 |
Ho KC, Zhou Z, She YM, Chun A, Cyr TD and Yang X (2011) Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proc Natl Acad Sci U S A 108, 4870-5
DOI
|
66 |
Zhao B, Li L, Wang L, Wang CY, Yu J and Guan KL (2012) Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev 26, 54-68
DOI
|
67 |
Wada K, Itoga K, Okano T, Yonemura S and Sasaki H (2011) Hippo pathway regulation by cell morphology and stress fibers. Development 138, 3907-3914
DOI
|
68 |
Chen HI and Sudol M (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci U S A 92, 7819-7823
DOI
|
69 |
Salah Z, Melino G and Aqeilan RI (2011) Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res 71, 2010-2020
DOI
|
70 |
Salah Z, Cohen S, Itzhaki E and Aqeilan RI (2013) NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation. Cell Cycle 12, 3817-3823
DOI
|
71 |
Cao L, Wang P, Gao Y, Lin X, Wang F and Wu S (2014) Ubiquitin E3 ligase dSmurf is essential for Wts protein turnover and Hippo signaling. Biochem Biophys Res Commun 454, 167-171
DOI
|
72 |
Bae SJ, Kim M, Kim SH et al (2015) NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway. Nat Commun 6, 6314
DOI
|
73 |
Yeung B, Ho KC and Yang X (2013) WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells. PLoS One 8, e61027
DOI
|